Your session is about to expire
← Back to Search
Imaginal Exposure Therapy for Eating Disorders (In-vivo IE II Trial)
N/A
Waitlist Available
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must have at least one significant eating disorder related fear.
Must currently meet criteria for anorexia, sub-clinical anorexia, bulimia, or sub-clinical bulimia (using the eating disorder diagnostic scale), OR have met criteria for one of these eating disorders in the last year, OR endorse significant eating disorder fears
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year and 10 weeks
Awards & highlights
In-vivo IE II Trial Summary
This trial will test if a therapy that involves imagining oneself in feared situations can help to ease symptoms of eating disorders and anxiety.
Who is the study for?
This trial is for adults with significant fears related to eating disorders such as anorexia or bulimia, whether currently diagnosed or within the last year. It's not open to those with binge eating disorder, unspecified eating disorders, mania, psychosis, suicidal thoughts, or under 18s.Check my eligibility
What is being tested?
The study is examining if imaginal exposure therapy can help reduce symptoms of anxiety and various eating disorders by having participants face their fears in a controlled environment.See study design
What are the potential side effects?
While the trial involves psychological therapy rather than medication, side effects may include increased anxiety or emotional distress during early stages of treatment as patients confront difficult emotions and memories.
In-vivo IE II Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You must have at least one major fear related to your eating disorder.
Select...
You currently have or have had anorexia, bulimia, or related eating disorders in the past year. Or you have significant fears related to eating disorders.
In-vivo IE II Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year and 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year and 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Body Mass Index (BMI) at 1-10 Weeks and at 1 year
EDEQ (Eating Disorder Examination Questionnaire) at 1-10 Weeks and at 1 year
SUDS (Subjective Units of Distress Scale) at 1-10 Weeks and at 1 year
In-vivo IE II Trial Design
1Treatment groups
Experimental Treatment
Group I: Imaginal Exposure SessionExperimental Treatment1 Intervention
All participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
imaginal exposure therapy
2017
N/A
~50
Find a Location
Who is running the clinical trial?
University of LouisvilleLead Sponsor
336 Previous Clinical Trials
75,897 Total Patients Enrolled
1 Trials studying Exposure
208 Patients Enrolled for Exposure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must have at least one major fear related to your eating disorder.You have a history of mental health conditions such as mania, psychosis, or suicidal thoughts.You have a specific type of eating disorder called binge eating disorder or an unspecified eating disorder. Or, you don't meet the criteria for an eating disorder.You currently have or have had anorexia, bulimia, or related eating disorders in the past year. Or you have significant fears related to eating disorders.
Research Study Groups:
This trial has the following groups:- Group 1: Imaginal Exposure Session
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies in this trial available for participants?
"The information on the clinicaltrials.gov database reveals that this trial is not presently recruiting patients; however, it was initially posted in May 2017 and last updated in October 2022. There are currently 167 other trials actively welcoming participants."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger